Showing results (1991-2000 of 2,127) with videos related to
Sort By:
Pageof 213
Nature Communications|March 19, 2026
A bioinspired microdevice unifying energy storage and actuation through hydration controlWenlan Zhang, Leandro Merces, Jiachen Ma, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonistsRobert G Schmidt, Erol K Bayburt, Steven P Latshaw, et al.BMJ Quality & Safety|March 9, 2016
Why patients' disruptive behaviours impair diagnostic reasoning: a randomised experimentSílvia Mamede, Tamara Van Gog, Stephanie C E Schuit, et al.Nature Materials|May 4, 2010
Precise control of thermal conductivity at the nanoscale through individual phonon-scattering barriersG Pernot, M Stoffel, I Savic, et al.Human Gene Therapy|February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trialB Wittig, A Märten, T Dorbic, et al.Advanced Materials (Deerfield Beach, Fla.)|February 19, 2016
Fully Integrated Organic Nanocrystal Diode as High Performance Room Temperature NO2 SensorAbdur Rehman Jalil, Hao Chang, Vineeth Kumar Bandari, et al.The Journal of Biological Chemistry|December 25, 2000
Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablationY Sato, H Kiriazis, A Yatani, et al.European Journal of Heart Failure|November 25, 2014
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trialFrank Edelmann, Volker Holzendorf, Rolf Wachter, et al.Nanoscale|October 7, 2020
Human spermbots for patient-representative 3D ovarian cancer cell treatmentHaifeng Xu, Mariana Medina-Sánchez, Wunan Zhang, et al.The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.Pageof 213